Advertisement
Advertisement

NUTX

NUTX logo

Nutex Health Inc. Common Stock

183.36
USD
Sponsored
+3.81
+2.12%
Jul 09, 15:59 UTC -4
Closed
exchange

After-Market

183.67

+0.31
+0.17%

NUTX Earnings Reports

Positive Surprise Ratio

NUTX beat 8 of 14 last estimates.

57%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$219.33M
/
$4.75
Implied change from Q1 26 (Revenue/ EPS)
+1.31%
/
-27.15%
Implied change from Q2 25 (Revenue/ EPS)
-10.10%
/
-261.02%

Nutex Health Inc. Common Stock earnings per share and revenue

On Apr 30, 2026, NUTX reported earnings of 6.52 USD per share (EPS) for Q1 26, beating the estimate of 4.97 USD, resulting in a 30.99% surprise. Revenue reached 216.49 million, compared to an expected 232.45 million, with a -6.87% difference. The market reacted with a +17.09% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of 4.75 USD, with revenue projected to reach 219.33 million USD, implying an decrease of -27.15% EPS, and increase of 1.31% in Revenue from the last quarter.
FAQ
For Q1 2026, Nutex Health Inc. Common Stock reported EPS of $6.52, beating estimates by 30.99%, and revenue of $216.49M, -6.87% below expectations.
The stock price moved up 17.09%, changed from $119.20 before the earnings release to $139.57 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 5 analysts, Nutex Health Inc. Common Stock is expected to report EPS of $4.75 and revenue of $219.33M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement